The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

6 Jan 2016 13:47

RNS Number : 0373L
Non-Standard Finance PLC
06 January 2016
 

THIS ANNOUNCEMENT AND THE INFORMATION HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

This Announcement is an advertisement and not a prospectus. Neither this Announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not purchase or subscribe for any transferable securities referred to in this Announcement except on the basis of information contained in the Prospectus (as defined below). This Announcement is not an offer to sell, or a solicitation of an offer to acquire, securities in the United States, Australia, Canada, New Zealand, Japan, the Republic of South Africa or in any other jurisdiction.

 

Please see the important notice at the end of this Announcement.

 

 

Non-Standard Finance plc

 

(the "Company" or "NSF")

 

 

Results of General Meeting

 

 

On 4 December 2015, NSF announced its intention to raise approximately £160 million by way of placing and open offer (the "Capital Raising"), to part-fund the proposed acquisition of Everyday Loans (the "Acquisition"), which is expected to complete by no later than 1 May 2016 ("Completion").

 

Further to the announcement dated 5 January 2016 setting out the results of the Capital Raising, the Company is pleased to announce that at the General Meeting held at 11.00 a.m. today, the resolutions required in connection with the Capital Raising (the "Resolutions") were duly passed without amendment. The full text of the Resolutions and the notice convening the General Meeting is set out in the prospectus published by the Company on 7 December 2015 relating to the Acquisition, the Capital Raising and the Readmission (the "Prospectus"). The Resolutions have also been submitted to the UK Listing Authority, and will shortly be available for inspection at the UK Listing Authority's National Storage Mechanism, which can be accessed at http://www.morningstar.co.uk/uk/NSM.

 

The results are set out below:

 

Resolution

For

Against

Total

% of ISC voted

Withheld*

1. Authority extending the directors' power to allot shares

62,838,159 99.66%

216,678

0.34%

63,054,837

59.89

3,000,500

 

2. Authority to disapply pre-emption rights in order to allot shares

62,802,747

99.60%

252,090

0.40%

63,054,837

59.89

3,000,500 

 

* A vote 'withheld' is not a vote under English law and is not counted in the calculation of votes 'for' and 'against' a Resolution.

 

Commenting on the result of the Capital Raising, John van Kuffeler, Chairman of NSF said:

 

"Following the announcement of the proposed acquisition of Everyday Loans, we are delighted that shareholder reaction to the associated capital raising has been so positive with all resolutions passed.

 

"The acquisition of Everyday Loans is a second significant step in the implementation of our strategy, first outlined at IPO. We are now looking forward to completing the transaction and growing the business."

 

 

The Capital Raising remains conditional on the Placing and Open Offer Agreement becoming unconditional in all respects and not having been terminated in accordance with its terms.

 

The Capital Raising is not itself conditional on Completion. The Capital Raising may therefore complete while the Acquisition does not. If Admission of the New Ordinary Shares is effected but Completion does not occur within six months of such Admission, the Directors' current intention is that the proceeds of the Capital Raising will be invested on a short-term basis while they evaluate how best to return substantially all of the proceeds to Shareholders.

 

Application has been made to the FCA for the New Ordinary Shares, comprising 188,235,825 ordinary shares, to be admitted to listing on the standard listing segment of the Official List and to the London Stock Exchange for such shares to be admitted to trading on the Main Market for listed securities. It is expected that Admission will become effective, and dealings in the New Ordinary Shares will commence, at 8.00 a.m. on 7 January 2016.

 

New Ordinary Shares issued under the Capital Raising in uncertificated form are expected to be credited to CREST accounts by 8.00 a.m. on 7 January 2016, and definitive share certificates for the New Ordinary Shares issued under the Capital Raising in certificated form are expected to be despatched within 14 days of Admission.

 

The Enlarged Share Capital of the Company following Admission will be 293,520,270 Ordinary Shares in aggregate. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of interest in, the Company.

 

This announcement should be read in conjunction with the Prospectus. The Prospectus is available from the Company's registered office at 5th Floor, 6 St Andrew Street, London, EC4A 3AE and online at www.nonstandardfinance.com and the National Storage Mechanism at www.morningstar.co.uk/uk/nsmUnless defined herein, capitalised terms used in this announcement shall have the meaning attributed to them in the Prospectus.

 

 

- Ends -

 

 

For more information

 

Non-Standard Finance plc

John van Kuffeler, Chairman

Nick Teunon, Chief Financial Officer & Company Secretary

c/o Bell Pottinger

 

+44 (0) 20 3772 2500

J.P. Morgan Cazenove (Global Co-ordinator, Bookrunner, Underwriter and Joint Corporate Broker)

Laurence Hollingworth

Mike Collar

Nicholas Hall

Virginia Khoo

 

+44 (0) 20 7742 4000

Peel Hunt LLP (Lead Manager and Joint Corporate Broker)

Adrian Haxby

Alastair Rae

Guy Wiehahn

Edward Fox

 

+44 (0) 20 7418 8900

Bell Pottinger

Olly Scott

Molly Stewart

+44 (0) 20 3772 2500

 

IMPORTANT NOTICE:

This Announcement is an advertisement and not a prospectus. Neither this Announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not purchase or subscribe for any transferable securities referred to in this Announcement except on the basis of information contained in the Prospectus.

 

This Announcement, and the information contained therein, is the sole responsibility of the Company and its directors. It is for information purposes only and is not intended to and does not constitute an offer or invitation to purchase or subscribe for, or any solicitation to purchase or subscribe for any of the securities referred to herein. The information contained herein is not for release, distribution or publication, directly or indirectly, in or into the United States, Canada, Australia, Japan, New Zealand, South Africa or any other jurisdiction where applicable laws prohibit its release, distribution or publication. The distribution of this Announcement in other jurisdictions may be restricted by law and persons into whose possession this document comes must inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the applicable securities laws.

 

The Ordinary Shares have not been and will not be registered under applicable securities laws of Australia, Canada, Japan, New Zealand or South Africa. Subject to certain exceptions, the Ordinary Shares may not be offered, sold, resold, transferred or distributed directly or indirectly, within, into or in Australia, Canada, Japan, New Zealand, South Africa or any other jurisdiction where such offer or sale would violate the relevant securities laws of such jurisdiction.

 

The Ordinary Shares have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act") or under the securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, resold, renounced, transferred or delivered, directly or indirectly, into or within the United States except pursuant to applicable exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of the New Ordinary Shares in the United States and no public offer of securities is being made in any jurisdiction by virtue of this Announcement.

 

J.P. Morgan Securities plc (which conducts its UK investment banking business as J.P. Morgan Cazenove) ("J.P. Morgan Cazenove") is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom. Peel Hunt LLP ("Peel Hunt") is authorised and regulated by the Financial Conduct Authority. J.P. Morgan Cazenove and Peel Hunt are acting exclusively for the Company and for no-one else in connection with the Capital Raising, Admission and Readmission and will not be responsible to anyone other than the Company for providing the protections afforded to customers of J.P. Morgan Cazenove and Peel Hunt respectively or for providing advice in relation to the contents of this Announcement, the Capital Raising and Admission or any transaction, arrangement, or other matter referred to in this Document or any matter referred to in it. Neither of J.P. Morgan Cazenove or Peel Hunt makes any representation, express or implied, as to the contents of this Announcement or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under stature or otherwise) to any person who is not a client in connection with this Announcement, any statements herein or otherwise.

 

Each of Bell Pottinger LLP ("Bell Pottinger"), J.P. Morgan Cazenove, Peel Hunt and their respective affiliates expressly disclaims any obligation or undertaking to update, review or revise any forward-looking statement contained in this Announcement whether as a result of new information, future developments or otherwise.

 

Certain figures contained in this Announcement, including financial information, have been subject to rounding adjustments. Accordingly, in certain instances, the sum or percentage change of the numbers contained in this Announcement may not conform exactly with the total figure given.

 

Except as explicitly stated, neither the content of the Group's nor Everyday Loans' website, nor any website accessible by hyperlinks on the Group's or Everyday Loans' website is incorporated in, or forms part of, this Announcement.

 

This Announcement does not constitute a recommendation concerning the Capital Raising. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. The contents of this Announcement are not to be construed as legal, business, financial or tax advice. Each Shareholder or prospective investor should consult his, her or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMXQLFBQFFXBBX
Date   Source Headline
10th Jul 20237:00 amRNSNotice of Delisting
7th Jul 20238:06 amRNSSuspension of Trading in Ordinary Shares
5th Jul 20233:18 pmRNSUpdate on Delisting and Suspension of Shares
23rd Jun 20232:51 pmRNSFiling of Annual General Meeting Resolutions
23rd Jun 20232:49 pmRNSResult of AGM
23rd Jun 20237:00 amRNSUpdate on Scheme, Delisting & Directorate Change
23rd May 20237:00 amRNSStandard form for notification of major holdings
18th May 20237:00 amRNSProposed Recapitalisation & Directorate Change 
28th Apr 20235:51 pmRNSReplacement: Update on scheme of arrangement
28th Apr 20233:33 pmRNSUpdate on scheme of arrangement
28th Apr 20238:21 amRNSAudited full year results to 31 December 2022
14th Apr 20237:00 amRNSProposed Release of Debt and Directorate Change
4th Apr 20234:14 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:39 amRNSLaunch of Scheme & Proposed Recapitalisation
17th Mar 20237:00 amRNSScheme of Launch & Proposed Recapitalisation
13th Feb 20237:00 amRNS2022 Trading Statement
4th Jan 202310:15 amRNSDirector/PDMR Shareholding
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20225:50 pmRNSDirector/PDMR Shareholding
29th Sep 20224:40 pmRNSSecond Price Monitoring Extn
29th Sep 20224:37 pmRNSPrice Monitoring Extension
28th Sep 20227:05 amRNSUpdate on Current Status and Regulatory matters
28th Sep 20227:05 amRNSUnaudited Half Year Results to 30 June 2022
27th Jul 20224:41 pmRNSSecond Price Monitoring Extn
27th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jul 20224:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:35 pmRNSPrice Monitoring Extension
6th Jul 20224:40 pmRNSSecond Price Monitoring Extn
6th Jul 20224:36 pmRNSPrice Monitoring Extension
4th Jul 20224:16 pmRNSDirector/PDMR Shareholding
15th Jun 20223:25 pmRNSFunding facilities update
26th May 20224:42 pmRNSFilings of AGM Resolutions
26th May 20222:49 pmRNSResults of Annual General Meeting
29th Apr 202212:00 pmRNSDirectorate Change
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
29th Apr 20227:00 amRNSAudited full year results to 31 December 2021
1st Apr 20224:40 pmRNSSecond Price Monitoring Extn
1st Apr 20224:35 pmRNSPrice Monitoring Extension
29th Mar 20229:26 amRNSDirector/PDMR Shareholding
17th Mar 20224:41 pmRNSSecond Price Monitoring Extn
17th Mar 20224:36 pmRNSPrice Monitoring Extension
16th Mar 20224:41 pmRNSSecond Price Monitoring Extn
16th Mar 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.